Tag archive for ‘Opko’
Gali Weinreb On Tuesday, December 16th, 2014

Pfizer buys Israel-developed hormone drug from Opko

– Pfizer will pay $295 million for the growth hormone treatment and up to $275 million in milestone payments, and royalties. Pfizer Inc. (NYSE: PFE) has acquired the development and commercialization More...

Gali Weinreb On Monday, November 10th, 2014

Phillip Frost seeks SciGen reverse merger

–  The Opko Health Chairman hopes to attain a value of over $100 million for the Rehovot-based vaccination developer.   Vaccination company SciGen, controlled by Opko Health Inc. (NYSE: OPK; TASE: More...

Hillel Koren On Sunday, October 12th, 2014

TASE follows Wall Street south

– Dual-listed stocks under particular pressure are Opko, Teva, Israel Chemicals, Nice Systems, and Perrigo. – The Tel Aviv Stock Exchange returned from the Sukkot holiday today under pressure More...

Globes On Monday, July 29th, 2013

Phillip Frost can vote on Prolor-Opko merger on August 28

– Dr. Phillip Frost, the chairman of both Opko and Prolor, has the right to vote on the merger of the two companies on August 28. – Phillip Frost/ Getty – / By Gali Weinreb / Dr. Phillip More...

Ilan Shavit On Thursday, April 25th, 2013

Opko Health acquires Israeli Prolor Biotech for $480 million – Pomerantz Law Firm Investigates

– Press release / SHAREHOLDER ALERT: Concerning the proposed  acquisition of PROLOR Biotech by OPKO Health in a transaction valued at approximately $480 million. – Phillip Frost Chairman of the Board More...

Wordpress site Developed by Fixing WordPress Problems